Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.731,20
0,01%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Inovio Pharmaceuticals Inc New (INO) Inovio Pharmaceuticals Inc New (INO) Notizie

Inovio Pharmaceuticals Inc New

INO
10,13
0,36 (3,68%)
01 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/5/202422:48PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
28/5/202422:01EDGAR2Form 8-K - Current report
22/5/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/5/202422:10EDGAR2Form 8-K - Current report
13/5/202422:05PRNUSINOVIO Reports First Quarter 2024 Financial Results and..
13/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/5/202414:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
29/4/202414:00PRNUSINOVIO to Report First Quarter 2024 Financial Results on May..
16/4/202400:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
26/3/202423:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
06/3/202422:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202413:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
06/3/202412:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
21/2/202414:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
07/2/202417:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
02/2/202414:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
01/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202422:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
25/1/202422:02EDGAR2Form 8-K - Current report
23/1/202414:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
22/1/202414:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
12/1/202423:27EDGAR2Form 8-K - Current report
04/1/202414:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
03/1/202414:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
28/11/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202322:00EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202322:35EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:15EDGAR2Form 8-K - Current report
09/11/202322:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
09/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:01EDGAR2Form 8-K - Current report
Apertura: 9,81 Min: 9,70 Max: 10,2399
Chiusura: 9,77

La tua Cronologia

NASDAQ
INO
Inovio Pharmaceuticals
BOV
VIVT3M
TELEF BRASIL ON
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network